Mike Coyle serves as Executive Vice President and President for the Cardiovascular Portfolio, a position he’s held since November 2020. In this role, Mike is responsible for optimizing Medtronic enterprise performance by supporting capital allocation, talent management, investments, and collaboration to create value across all of our Medtronic Operating Units (OUs), including the eight OUs that are organized under the Cardiovascular Portfolio.
Mike joined Medtronic in 2009 as Executive Vice President and Group President of the Cardiac and Vascular Group, where he oversaw and provided strategic direction for four Medtronic business divisions.
Prior to joining Medtronic, Mike provided leadership consulting services to private equity, venture capital, and medical device technology firms. From 2001 to 2007, he served as a divisional president at St. Jude Medical, where he led the company’s global pacemaker, implantable cardioverter defibrillator, and cardiac resynchronization businesses. He also led the company’s Daig Catheter division in an earlier president role. Additionally, Mike held numerous leadership positions at Eli Lilly & Company.
He earned a bachelor’s degree from Case Western Reserve University and a master’s degree in business administration from the Wharton School of Business, University of Pennsylvania. He currently serves on the board of directors for Haemonetics Corporation. He is also an advisor on the Case Western Reserve University School of Engineering BME Think Tank.
Mike is proud to serve as the executive sponsor of the Medtronic Women’s Network and past executive sponsor of the Asian Impact at Medtronic employee resource network. He champions a diverse, inclusive culture in Cardiovascular as a vital driver of innovation.
An avid traveler, Mike enjoys sharing trips with his wife, Laura, and his two children, Maya and Quinn.
What is Michael J. Coyle's net worth?
The estimated net worth of Michael J. Coyle is at least $16.31 million as of November 14th, 2019. Mr. Coyle owns 189,162 shares of Medtronic stock worth more than $16,307,656 as of November 24th. This net worth estimate does not reflect any other investments that Mr. Coyle may own. Learn More about Michael J. Coyle's net worth.
How do I contact Michael J. Coyle?
Has Michael J. Coyle been buying or selling shares of Medtronic?
Michael J. Coyle has not been actively trading shares of Medtronic in the last ninety days. Most recently, Michael J. Coyle sold 2,102 shares of the business's stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $109.77, for a transaction totalling $230,736.54. Following the completion of the sale, the executive vice president now directly owns 189,162 shares of the company's stock, valued at $20,764,312.74. Learn More on Michael J. Coyle's trading history.
Who are Medtronic's active insiders?
Medtronic's insider roster includes Richard Anderson (Director), Michael Coyle (EVP), Gary Ellis (EVP), Hooman Hakami (EVP), Bryan Hanson (EVP), Omar Ishrak (Chairman), Richard Kuntz (SVP), Bradley Lerman (SVP), John Liddicoat (EVP), Michael Marinaro (EVP), Geoffrey Martha (Chairman of the Board & CEO), Karen Parkhill (CFO), Sean Salmon (EVP), Gregory Smith (EVP), Carol Surface (SVP), Rob Ten Hoedt (EVP), Brett Wall (EVP), Brett Wall (EVP), and Robert White (EVP). Learn More on Medtronic's active insiders.
Are insiders buying or selling shares of Medtronic?
During the last year, insiders at the medical technology company sold shares 4 times. They sold a total of 55,659 shares worth more than $4,695,766.41. The most recent insider tranaction occured on June, 7th when CEO Geoffrey Martha sold 19,113 shares worth more than $1,601,096.01. Insiders at Medtronic own 0.2% of the company.
Learn More about insider trades at Medtronic. Information on this page was last updated on 6/7/2024.
